• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种在免疫健全小鼠中建立骨转移性前列腺癌的新模型。

A novel model of bone-metastatic prostate cancer in immunocompetent mice.

作者信息

Power Carl A, Pwint Hnin, Chan Jeffrey, Cho Jae, Yu Yan, Walsh William, Russell Pamela J

机构信息

Oncology Research Centre, Prince of Wales Hospital, Randwick, NSW, Australia.

出版信息

Prostate. 2009 Nov 1;69(15):1613-23. doi: 10.1002/pros.21010.

DOI:10.1002/pros.21010
PMID:19585491
Abstract

BACKGROUND

Bone metastasis is a frequent and catastrophic consequence of prostate cancer for which only palliative treatment is available. Animal models of bone metastatic prostate cancer are necessary for understanding disease mechanisms but few models exist.

METHODS

We have used the murine prostate carcinoma cell line RM1 to generate a bone metastatic model of prostate cancer. Repeated intracardiac injection of RM1 cells followed by isolation of cells from bone tumors has yielded a cell line with strong bone-metastatic potential, RM1 bone metastatic (BM).

RESULTS

This cell line metastasizes to multiple bony sites in over 95% of injected C57BL/6 mice and is far less tropic to soft tissues. Bone tumors produced by the RM1(BM) cell line show no preference for particular skeletal sites as most bones are affected. Histology, and micro-computed tomography show that RM1(BM) cells form osteolytic tumors, but with evidence of osteoblastic changes. In vitro the RM1 cells express E-cadherin but not vimentin, do not form colonies in soft agar, are non-invasive but are more motile than the parent cell line.

CONCLUSIONS

This model provides a novel means for identifying cellular and molecular mechanisms that contribute to bone metastasis and allow for preclinical testing of therapies to prevent and treat tumor metastasis to bone. Finally as the syngeneic tumor cells are injected into immunocompetent mice, this model will provide a means to study interactions between the immune system, tumors and bone, and therapies that target such interactions.

摘要

背景

骨转移是前列腺癌常见且严重的后果,目前仅有姑息治疗手段。骨转移性前列腺癌的动物模型对于理解疾病机制至关重要,但现有的模型很少。

方法

我们使用小鼠前列腺癌细胞系RM1建立了前列腺癌骨转移模型。通过反复心内注射RM1细胞,随后从骨肿瘤中分离细胞,获得了具有强大骨转移潜能的细胞系RM1骨转移(BM)细胞系。

结果

该细胞系在超过95%的注射C57BL/6小鼠中转移至多个骨部位,对软组织的趋向性远低于此。RM1(BM)细胞系产生的骨肿瘤对特定骨骼部位无偏好,大多数骨骼都会受到影响。组织学和微型计算机断层扫描显示,RM1(BM)细胞形成溶骨性肿瘤,但有骨母细胞变化的证据。在体外,RM1细胞表达E-钙黏蛋白但不表达波形蛋白,在软琼脂中不形成集落,无侵袭性,但比亲代细胞系更具运动性。

结论

该模型为识别促成骨转移的细胞和分子机制提供了一种新方法,并允许对预防和治疗肿瘤骨转移的疗法进行临床前测试。最后,由于将同基因肿瘤细胞注射到具有免疫活性的小鼠体内,该模型将提供一种研究免疫系统、肿瘤和骨之间相互作用以及针对此类相互作用的疗法的方法。

相似文献

1
A novel model of bone-metastatic prostate cancer in immunocompetent mice.一种在免疫健全小鼠中建立骨转移性前列腺癌的新模型。
Prostate. 2009 Nov 1;69(15):1613-23. doi: 10.1002/pros.21010.
2
A metastatic human prostate cancer model using intraprostatic implantation of tumor produced by PC-3 neolacZ transfected cells.一种转移性人类前列腺癌模型,通过在前列腺内植入由PC-3新乳糖操纵子转染细胞产生的肿瘤构建而成。
Int J Oncol. 2003 Dec;23(6):1569-74.
3
In vivo models of prostate cancer metastasis to bone.前列腺癌骨转移的体内模型。
J Urol. 2005 Sep;174(3):820-6. doi: 10.1097/01.ju.0000169133.82167.aa.
4
Development of an animal model for prostate cancer cell metastasis to adult human bone.前列腺癌细胞转移至成人生骨的动物模型的建立。
Anticancer Res. 2001 Mar-Apr;21(2A):971-8.
5
Type I collagen receptor (alpha 2 beta 1) signaling promotes the growth of human prostate cancer cells within the bone.I型胶原蛋白受体(α2β1)信号传导促进人前列腺癌细胞在骨内的生长。
Cancer Res. 2006 Sep 1;66(17):8648-54. doi: 10.1158/0008-5472.CAN-06-1544.
6
Evaluation of human fetal bone implants in SCID mice as a model of prostate cancer bone metastasis.评估严重联合免疫缺陷(SCID)小鼠体内人胎儿骨植入物作为前列腺癌骨转移模型的情况。
Oncol Rep. 2006 Mar;15(3):519-24.
7
Establishment of a novel species- and tissue-specific metastasis model of human prostate cancer in humanized non-obese diabetic/severe combined immunodeficient mice engrafted with human adult lung and bone.在移植了人类成人肺和骨的人源化非肥胖糖尿病/严重联合免疫缺陷小鼠中建立一种新型的人前列腺癌物种和组织特异性转移模型。
Cancer Res. 2001 Mar 1;61(5):2177-82.
8
Evaluation of metastatic potential in prostate carcinoma: an in vivo model.前列腺癌转移潜能的评估:一种体内模型
Int J Oncol. 2004 Dec;25(6):1713-20.
9
The bisphosphonate YM529 inhibits osteoblastic bone tumor proliferation of prostate cancer.双膦酸盐YM529抑制前列腺癌的成骨细胞性骨肿瘤增殖。
Prostate. 2007 Jun 15;67(9):999-1009. doi: 10.1002/pros.20592.
10
[Preclinical models of prostate cancer].[前列腺癌的临床前模型]
Bull Cancer. 2005 Feb;92(2):129-41.

引用本文的文献

1
Blood-based detection of MMP11 as a marker of prostate cancer progression regulated by the ALDH1A1-TGF-β1 signaling mechanism.基于血液检测基质金属蛋白酶11作为由醛脱氢酶1A1-转化生长因子-β1信号传导机制调控的前列腺癌进展标志物。
J Exp Clin Cancer Res. 2025 Mar 24;44(1):105. doi: 10.1186/s13046-025-03299-6.
2
Multiple cancer cell types release LIF and Gal3 to hijack neural signals.多种癌细胞会释放 LIF 和 Gal3 来劫持神经信号。
Cell Res. 2024 May;34(5):345-354. doi: 10.1038/s41422-024-00946-z. Epub 2024 Mar 11.
3
ALDH1A1 drives prostate cancer metastases and radioresistance by interplay with AR- and RAR-dependent transcription.
ALDH1A1 通过与 AR 和 RAR 依赖性转录的相互作用,驱动前列腺癌转移和放射抵抗。
Theranostics. 2024 Jan 1;14(2):714-737. doi: 10.7150/thno.88057. eCollection 2024.
4
MDA-9/Syntenin in the tumor and microenvironment defines prostate cancer bone metastasis.MDA-9/Syntenin 在肿瘤和微环境中定义了前列腺癌骨转移。
Proc Natl Acad Sci U S A. 2023 Nov 7;120(45):e2307094120. doi: 10.1073/pnas.2307094120. Epub 2023 Nov 3.
5
Animal models of cancer metastasis to the bone.癌症骨转移的动物模型。
Front Oncol. 2023 Apr 5;13:1165380. doi: 10.3389/fonc.2023.1165380. eCollection 2023.
6
The genomic regulation of metastatic dormancy.转移性休眠的基因组调控。
Cancer Metastasis Rev. 2023 Mar;42(1):255-276. doi: 10.1007/s10555-022-10076-w. Epub 2023 Jan 5.
7
Exosomal miRNAs from Prostate Cancer Impair Osteoblast Function in Mice.前列腺癌细胞外体 miRNA 可损害小鼠成骨细胞功能。
Int J Mol Sci. 2022 Jan 24;23(3):1285. doi: 10.3390/ijms23031285.
8
Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment.人前列腺癌骨转移具有可操作的免疫抑制微环境。
Cancer Cell. 2021 Nov 8;39(11):1464-1478.e8. doi: 10.1016/j.ccell.2021.09.005. Epub 2021 Oct 15.
9
ATR Inhibition Induces CDK1-SPOP Signaling and Enhances Anti-PD-L1 Cytotoxicity in Prostate Cancer.ATR 抑制诱导 CDK1-SPOP 信号传导并增强前列腺癌中抗 PD-L1 的细胞毒性。
Clin Cancer Res. 2021 Sep 1;27(17):4898-4909. doi: 10.1158/1078-0432.CCR-21-1010. Epub 2021 Jun 24.
10
Exploitation of the chick embryo chorioallantoic membrane (CAM) as a platform for anti-metastatic drug testing.利用鸡胚尿囊膜(CAM)作为抗转移药物测试平台。
Sci Rep. 2020 Oct 9;10(1):16876. doi: 10.1038/s41598-020-73632-w.